Abstract Title:

Microbiota-gut brain axis involvement in neuropsychiatric disorders.

Abstract Source:

Expert Rev Neurother. 2019 Jul 1. Epub 2019 Jul 1. PMID: 31260640

Abstract Author(s):

Luigi Francesco Iannone, Alberto Preda, Hervé M Blottière, Gerard Clarke, Diego Albani, Vincenzo Belcastro, Marco Carotenuto, Anna Cattaneo, Rita Citraro, Cinzia Ferraris, Francesca Ronchi, Gaia Luongo, Elisa Santocchi, Letizia Guiducci, Pietro Baldelli, Paola Iannetti, Sigrid Pedersen, Andrea Petretto, Stefania Provasi, Kaja Selmer, Alberto Spalice, Anna Tagliabue, Alberto Verrotti, Nicola Segata, Jakob Zimmermann, Carlo Minetti, Paolo Mainardi, Carmen Giordano, Sanjay Sisodiya, Federico Zara, Emilio Russo, Pasquale Striano

Article Affiliation:

Luigi Francesco Iannone


Introduction The microbiota-gut brain (MGB) axis is the bidirectional communication between the intestinal microbiota and the brain. An increasing body of preclinical and clinical evidence has revealed that the gut microbial ecosystem can affect neuropsychiatric health. However, there is still a need of further studies to elucidate the complex gene-environment interactions and the role of the MGB axis in neuropsychiatric diseases, with the aim of identifying biomarkers and new therapeutic targets, to allow early diagnosis and improving treatments. Areas covered To review the role of MGB axis in neuropsychiatric disorders, prediction and prevention of disease through exploitation, integration and combination of data from existing gut microbiome/microbiota projects and appropriate other International"-Omics"studies. The authors also evaluated the new technological advances to investigate and modulate, through nutritional and other interventions, the gut microbiota. Expert opinion The clinical studies have documented an association between alterations in gut microbiota composition and/or function, whereas the preclinical studies support a role for the gut microbiota in impacting behaviours which are of relevance to psychiatry and other central nervous system (CNS) disorders. Targeting MGB axis could be an additional approach for treating CNS disorders and all conditions in which alterations of the gut microbiota are involved.

Study Type : Review
Additional Links

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.